The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation

AUTOR(ES)

Wang, Gan

FONTE

Oxford University Press

RESUMO

XPC is an important DNA damage recognition protein involved in DNA nucleotide excision repair. We have studied the role of the XPC protein in cisplatin treatment-mediated cell cycle regulation. Through the comparison of microarray data obtained from human normal fibroblasts and two individual XPC-defective cell lines, 486 genes were identified as XPC-responsive genes in the cisplatin treatment (with a minimal 1.5-fold change) and 297 of these genes were further mapped to biological pathways and gene ontologies. The cell cycle and cell proliferation-related genes were the most affected genes by the XPC defect in the cisplatin treatment. Many other cellular function genes were also affected by the XPC defect in the treatment. Western blot hybridization results revealed that the XPC defect reduced the p53 responses to the cisplatin treatment. The ability to activate caspase-3 was also attenuated in the XPC cells with the treatment. These results suggest that the XPC protein plays a critical role in initiating the cisplatin DNA damaging treatment-mediated signal transduction process, resulting in activation of the p53 pathway and cell cycle arrest that allow DNA repair and apoptosis to take place. These results reveal an important role of the XPC protein in the cancer prevention.

Documentos Relacionados

• Role of Mammalian Ecdysoneless in Cell Cycle Regulation*
• Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
• Role of Na+ cycle in cell volume regulation of Mycoplasma gallisepticum.
• Role of Swi4 in cell cycle regulation of CLN2 expression.
• Phosphorylation of the Oxytricha telomere protein: possible cell cycle regulation.